Division of Cardiothoracic and Vascular Surgery, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY, USA.
Department of Cardiovascular Surgery, Shonan-Kamakura General Hospital, Kamakura, Kanagawa, Japan.
Interact Cardiovasc Thorac Surg. 2021 Apr 19;32(4):573-581. doi: 10.1093/icvts/ivaa320.
Chronic kidney disease (CKD) is prevalent in patients undergoing cardiovascular surgery, and it negatively impacts procedural outcomes; however, its influence on the outcomes of aortic surgery has not been well studied. This study aims to elucidate the importance of CKD on the outcomes of aortic root replacement (ARR).
Patients who underwent ARR between 2005 and 2019 were retrospectively reviewed (n = 882). Patients were divided into 3 groups based on the Kidney Disease: Improving Global Outcomes criteria: Group 1 [estimated glomerular filtration rate (eGFR) ≥ 60 ml/min/1.73 m2, n = 421); Group 2 (eGFR = 30-59 ml/min/1.73 m2, n = 424); and Group 3 (eGFR < 30 ml/min/1.73 m2, n = 37). To reduce potential confounding, a propensity score matching was also performed between Group 1 and the combined group of Group 2 and Group 3. The primary end point was 10-year survival. Secondary end points were in-hospital mortality and perioperative morbidity.
Severe CKD patients presented with more advanced overall chronic and acute illnesses. Kaplan-Meier analysis showed a significant correlation between CKD stage and 10-year survival (log-rank P < 0.001). The number of events for Group 1 was 15, Group 2 was 49 and Group 3 was 11 in 10 years. Group 3 had significantly higher in-hospital mortality (13.5% vs 3.5% in Group 2 vs 0.7% in Group 1, P < 0.001) and stroke (8.1% vs 7.1% vs 1.2%, P < 0.001) as well as introduction to new dialysis (27.0% vs 5.4% vs 1.7%, P < 0.001). eGFR was shown to be an independent predictor of mortality (hazard ratio, 0.98; 95% confidence interval, 0.96-0.99). Comparison between propensity matched groups showed similar postoperative outcomes, and eGFR was still identified as a predictor of mortality (hazard ratio, 0.97; 95% confidence interval, 0.95-0.99).
Higher stage in CKD negatively impacts the long-term survival in patients who are undergoing ARR.
慢性肾脏病(CKD)在接受心血管手术的患者中较为常见,且对手术结果有负面影响;然而,其对主动脉手术结果的影响尚未得到充分研究。本研究旨在阐明 CKD 对主动脉根部置换术(ARR)结果的重要性。
回顾性分析了 2005 年至 2019 年期间接受 ARR 的患者(n=882)。根据肾脏病:改善全球结果(KDIGO)标准,患者被分为 3 组:第 1 组[估算肾小球滤过率(eGFR)≥60ml/min/1.73m2,n=421];第 2 组(eGFR=30-59ml/min/1.73m2,n=424);第 3 组(eGFR<30ml/min/1.73m2,n=37)。为了减少潜在的混杂因素,还在第 1 组和第 2 组和第 3 组的合并组之间进行了倾向评分匹配。主要终点为 10 年生存率。次要终点为住院死亡率和围手术期发病率。
严重 CKD 患者的整体慢性和急性疾病更为严重。Kaplan-Meier 分析显示,CKD 分期与 10 年生存率之间存在显著相关性(对数秩 P<0.001)。第 1 组的事件数为 15,第 2 组为 49,第 3 组为 10 年 11。第 3 组的住院死亡率(第 2 组为 13.5%,第 1 组为 3.5%,第 1 组为 0.7%,P<0.001)和中风(第 2 组为 8.1%,第 1 组为 7.1%,第 1 组为 1.2%,P<0.001)以及新引入透析(第 2 组为 27.0%,第 1 组为 5.4%,第 1 组为 1.7%,P<0.001)的发生率明显更高。eGFR 是死亡率的独立预测因子(风险比,0.98;95%置信区间,0.96-0.99)。匹配后的倾向评分组之间的比较显示出相似的术后结果,并且 eGFR 仍然被确定为死亡率的预测因子(风险比,0.97;95%置信区间,0.95-0.99)。
CKD 分期较高会对接受 ARR 的患者的长期生存产生负面影响。